ALERT: UPS driver chucks a 30-pound box at a dog sprinting at him at full speed, then tries to fight the owner.
"Why, what's the problem? Why you throwin' sh*t at my f*ckin' dog?"
🚨 WHY ARE THOUSANDS OF CANCER PATIENTS RESEARCHING DR. WILLIAM MAKIS' IVERMECTIN PROTOCOL?
A few years ago, almost nobody was talking about Ivermectin and cancer.
Today, one of the most talked-about repurposed medicine protocols in cancer circles comes from Dr. William Makis.
Why?
Because it brings together three things that continue to capture attention worldwide:
📌 Repurposed medicines
📌 Published research
📌 Real-world case reports
The chart above outlines dosing categories Dr. Makis has publicly discussed:
🟢 LOW DOSE (≤ 0.5 mg/kg)
Often discussed for:
• Cancers in remission
• Strong family history
• Genetic predisposition
🟡 MEDIUM DOSE (1.0 mg/kg)
Often discussed as a starting dose for many cancers.
🔵 HIGH DOSE (2.0 mg/kg)
Often discussed for aggressive cancers, including:
• Leukemia
• Pancreatic Cancer
• Brain Cancer
🔴 VERY HIGH DOSE (≥ 2.5 mg/kg)
Often discussed for:
• Extensive metastatic disease
• Advanced brain cancers
• Extremely poor prognosis cases
But what really gets people talking are the reported cases referenced in the chart.
📌 Dr. Tess Lawrie discussed a Stage 3 ovarian cancer case where CA125 reportedly fell from 288 to 22 after two months.
📌 Dr. Shankara Chetty discussed a prostate cancer patient whose PSA reportedly fell from 89.1 to 10.9 after two months.
📌 Dr. Allan Landnio discussed a Stage 4 gallbladder cancer patient who reportedly used 2.0 mg/kg/day for 14 months.
These are the kinds of reports that have thousands of patients digging deeper into the research.
Why are people paying attention?
Because Ivermectin wasn't originally developed as a cancer drug.
Yet researchers around the world have spent years investigating its potential effects on:
✅ Cancer stem cells
✅ Tumor metabolism
✅ Cell signaling pathways
✅ Drug resistance mechanisms
✅ Immune system regulation
Supporters point to:
✔️ Decades of use
✔️ A long safety history
✔️ Low cost
✔️ A growing body of published research
Critics argue that larger human clinical trials are still needed.
But regardless of where someone stands, one thing is clear:
People aren't just reading headlines anymore.
They're reading studies.
They're reviewing protocols.
They're comparing outcomes.
And they're asking questions.
Whether you agree with it or not, interest in repurposed medicines is growing rapidly.
That's why Dr. William Makis' Ivermectin protocol continues to be shared across cancer communities worldwide.
⚠️ Always consult a qualified healthcare professional before making treatment decisions.
The track fell silent as hope began to fade. Jockey Kosei Miura stayed beside the injured horse, refusing to walk away. Then, in an unforgettable moment, the horse rose to its feet—and the grandstand erupted in applause. 🐎❤️
A moment that reminded everyone what heart and resilience truly look like.
#Japan #HorseRacing #Respect #Inspiration